BioCentury | Jan 5, 2009
Finance

Restructuring watch

...that inhibits dihydrofolate reductase (DHFR) to treat complicated skin and skin structure infections (cSSSIs) 11/27/08 Meldex...
BioCentury | Dec 8, 2008
Company News

Meldex drug delivery news

...reduce costs. The company will close its Tampa, Florida, manufacturing facility and its London offices. Meldex...
...company had £500,000 ($995,000) in cash and six-month operating profit of £3.2 million ($6.4 million). Meldex International plc...
BioCentury | Sep 8, 2008
Company News

Meldex management update

Meldex International plc (LSE:MDX), Cambridge, U.K. Business: Drug delivery Departed: Richard Trevillion as CEO; Jim Murray will transition to executive chairman from non-executive chairman while the company seeks a new CEO WIR Staff...
BioCentury | Jul 21, 2008
Finance

Ebb & Flow

...company Immune Control . Acquisition anticipation Acquisition rumors pushed up shares of drug discovery company Meldex...
BioCentury | Jul 21, 2008
Company News

Meldex deal

...board formed an independent committee to consider possible acquisition offers. Further details were not disclosed. Meldex...
...gastrointestinal and respiratory conditions. The company reported revenues of £27.1 million ($53.8 million) in 2007. Meldex International plc...
BioCentury | Jun 30, 2008
Company News

Meldex board of directors update

Meldex International plc (LSE:MDX), Cambridge, U.K. Business: Drug delivery Resigned: Peter Ibbetson WIR Staff...
BioCentury | Jun 9, 2008
Company News

Meldex board of directors update

Meldex International plc (LSE:MDX), Cambridge, U.K. Business: Drug delivery Appointed: Jim Murray, a director, as chairman WIR Staff...
BioCentury | Jan 21, 2008
Finance

Ebb & Flow

...in a Phase II trial to treat proteinuria associated with diabetic kidney disease (see B3). Meldex...
BioCentury | Dec 17, 2007
Company News

Meldex board of directors update

Meldex International plc (LSE:MDX), Cambridge, U.K. Business: Drug delivery Appointed: Stewart Adkins WIR Staff...
BioCentury | Dec 3, 2007
Clinical News

Collunovar OraDisc regulatory update

...is an adhesive film containing 15 mg benzocaine designed to erode in about 90 minutes. Meldex International plc...
Items per page:
1 - 10 of 29
BioCentury | Jan 5, 2009
Finance

Restructuring watch

...that inhibits dihydrofolate reductase (DHFR) to treat complicated skin and skin structure infections (cSSSIs) 11/27/08 Meldex...
BioCentury | Dec 8, 2008
Company News

Meldex drug delivery news

...reduce costs. The company will close its Tampa, Florida, manufacturing facility and its London offices. Meldex...
...company had £500,000 ($995,000) in cash and six-month operating profit of £3.2 million ($6.4 million). Meldex International plc...
BioCentury | Sep 8, 2008
Company News

Meldex management update

Meldex International plc (LSE:MDX), Cambridge, U.K. Business: Drug delivery Departed: Richard Trevillion as CEO; Jim Murray will transition to executive chairman from non-executive chairman while the company seeks a new CEO WIR Staff...
BioCentury | Jul 21, 2008
Finance

Ebb & Flow

...company Immune Control . Acquisition anticipation Acquisition rumors pushed up shares of drug discovery company Meldex...
BioCentury | Jul 21, 2008
Company News

Meldex deal

...board formed an independent committee to consider possible acquisition offers. Further details were not disclosed. Meldex...
...gastrointestinal and respiratory conditions. The company reported revenues of £27.1 million ($53.8 million) in 2007. Meldex International plc...
BioCentury | Jun 30, 2008
Company News

Meldex board of directors update

Meldex International plc (LSE:MDX), Cambridge, U.K. Business: Drug delivery Resigned: Peter Ibbetson WIR Staff...
BioCentury | Jun 9, 2008
Company News

Meldex board of directors update

Meldex International plc (LSE:MDX), Cambridge, U.K. Business: Drug delivery Appointed: Jim Murray, a director, as chairman WIR Staff...
BioCentury | Jan 21, 2008
Finance

Ebb & Flow

...in a Phase II trial to treat proteinuria associated with diabetic kidney disease (see B3). Meldex...
BioCentury | Dec 17, 2007
Company News

Meldex board of directors update

Meldex International plc (LSE:MDX), Cambridge, U.K. Business: Drug delivery Appointed: Stewart Adkins WIR Staff...
BioCentury | Dec 3, 2007
Clinical News

Collunovar OraDisc regulatory update

...is an adhesive film containing 15 mg benzocaine designed to erode in about 90 minutes. Meldex International plc...
Items per page:
1 - 10 of 29